These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20953772)

  • 1. Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Jan; 399(2):635-49. PubMed ID: 20953772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
    Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of currently marketed heparin products: key tests for quality assurance.
    Keire DA; Ye H; Trehy ML; Ye W; Kolinski RE; Westenberger BJ; Buhse LF; Nasr M; Al-Hakim A
    Anal Bioanal Chem; 2011 Jan; 399(2):581-91. PubMed ID: 20680615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin.
    Monakhova YB; Diehl BWK; Do TX; Schulze M; Witzleben S
    J Pharm Biomed Anal; 2018 Feb; 149():128-132. PubMed ID: 29112901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining 1H NMR spectroscopy and multivariate regression techniques to quantitatively determine falsification of porcine heparin with bovine species.
    Monakhova YB; Diehl BW
    J Pharm Biomed Anal; 2015 Nov; 115():543-51. PubMed ID: 26319747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
    Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
    Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of heparin API by near infrared reflectance and Raman spectroscopy.
    Spencer JA; Kauffman JF; Reepmeyer JC; Gryniewicz CM; Ye W; Toler DY; Buhse LF; Westenberger BJ
    J Pharm Sci; 2009 Oct; 98(10):3540-7. PubMed ID: 19117047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Chem; 2011 Feb; 83(3):1030-9. PubMed ID: 21192734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
    Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
    Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of galactosamine impurities in heparin sodium using fluorescent labeling and conventional high-performance liquid chromatography.
    Itoh S; Hiruta Y; Hashii N; Fujita N; Natsuga T; Hattori T; Bando A; Sekimoto Y; Miyata K; Namekawa H; Mabuchi K; Sakai T; Shimahashi H; Kawai K; Yoden H; Koyama S; Herr SO; Natsuka S; Yamaguchi T; Kawasaki N
    Biologicals; 2013 Nov; 41(6):355-63. PubMed ID: 23827519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiality of proton nuclear magnetic resonance and multivariate calibration methods for the determination of dermatan sulfate contamination in heparin samples.
    Ruiz-Calero V; Saurina J; Galceran MT; Hernández-Cassou S; Puignou L
    Analyst; 2000 May; 125(5):933-8. PubMed ID: 10885058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of currently marketed heparin products: key tests for LMWH quality assurance.
    Ye H; Toby TK; Sommers CD; Ghasriani H; Trehy ML; Ye W; Kolinski RE; Buhse LF; Al-Hakim A; Keire DA
    J Pharm Biomed Anal; 2013 Nov; 85():99-107. PubMed ID: 23917037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
    Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
    J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal.
    Mourier PA; Guichard OY; Herman F; Viskov C
    J Pharm Biomed Anal; 2011 Jan; 54(2):337-44. PubMed ID: 20934294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm.
    Lee SE; Chess EK; Rabinow B; Ray GJ; Szabo CM; Melnick B; Miller RL; Nair LM; Moore EG
    Anal Bioanal Chem; 2011 Jan; 399(2):651-62. PubMed ID: 20949261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches.
    Keire DA; Mans DJ; Ye H; Kolinski RE; Buhse LF
    J Pharm Biomed Anal; 2010 Sep; 52(5):656-64. PubMed ID: 20233649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and characterization of heparin impurities.
    Beni S; Limtiaco JF; Larive CK
    Anal Bioanal Chem; 2011 Jan; 399(2):527-39. PubMed ID: 20814668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (1)H NMR signal at 2.10 ppm in the spectrum of KMnO(4)-bleached heparin sodium: identification of the chemical origin using an NMR-only approach.
    Kellenbach E; Sanders K; Michiels PJ; Girard FC
    Anal Bioanal Chem; 2011 Jan; 399(2):621-8. PubMed ID: 21069304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the composition of heparin mixtures from various origins using proton nuclear magnetic resonance and multivariate calibration methods.
    Ruiz-Calero V; Saurina J; Galceran MT; Hernández-Cassou S; Puignou L
    Anal Bioanal Chem; 2002 Jul; 373(4-5):259-65. PubMed ID: 12110977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.